Literature DB >> 15746533

Tissue transglutaminase (TG2) in cancer biology.

Lingegowda S Mangala1, Kapil Mehta.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15746533     DOI: 10.1159/000084237

Source DB:  PubMed          Journal:  Prog Exp Tumor Res        ISSN: 0079-6263


× No keyword cloud information.
  17 in total

Review 1.  Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.

Authors:  Morten A Karsdal; Tina Manon-Jensen; Federica Genovese; Jacob H Kristensen; Mette J Nielsen; Jannie Marie B Sand; Niels-Ulrik B Hansen; Anne-Christine Bay-Jensen; Cecilie L Bager; Aleksander Krag; Andy Blanchard; Henrik Krarup; Diana J Leeming; Detlef Schuppan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-03-12       Impact factor: 4.052

2.  MTA1 coregulation of transglutaminase 2 expression and function during inflammatory response.

Authors:  Krishna Sumanth Ghanta; Suresh B Pakala; Sirigiri Divijendra Natha Reddy; Da-Qiang Li; Sujit S Nair; Rakesh Kumar
Journal:  J Biol Chem       Date:  2010-12-14       Impact factor: 5.157

3.  The interaction of angiocidin with tissue transglutaminase.

Authors:  Darryl Z L'Heureux; Vicki L Rothman; George P Tuszynski
Journal:  Exp Mol Pathol       Date:  2009-11-18       Impact factor: 3.362

4.  Application of a global proteomic approach to archival precursor lesions: deleted in malignant brain tumors 1 and tissue transglutaminase 2 are upregulated in pancreatic cancer precursors.

Authors:  Wang Cheung; Marlene M Darfler; Hector Alvarez; Brian L Hood; Thomas P Conrads; Nils Habbe; David B Krizman; Jan Mollenhauer; Georg Feldmann; Anirban Maitra
Journal:  Pancreatology       Date:  2008-10-13       Impact factor: 3.996

Review 5.  Transglutaminase 2 inhibitors and their therapeutic role in disease states.

Authors:  Matthew Siegel; Chaitan Khosla
Journal:  Pharmacol Ther       Date:  2007-05-13       Impact factor: 12.310

6.  Crystallization and preliminary X-ray crystallographic studies of transglutaminase 2 in complex with Ca2+.

Authors:  Tae-Ho Jang; Hyun Ho Park
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-03-25       Impact factor: 1.056

7.  Transglutaminase 2 overexpression in tumor stroma identifies invasive ductal carcinomas of breast at high risk of recurrence.

Authors:  Jasmeet Assi; Gunjan Srivastava; Ajay Matta; Martin C Chang; Paul G Walfish; Ranju Ralhan
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

8.  Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury.

Authors:  Matthew Siegel; Pavel Strnad; R Edward Watts; Kihang Choi; Bana Jabri; M Bishr Omary; Chaitan Khosla
Journal:  PLoS One       Date:  2008-03-26       Impact factor: 3.240

9.  Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion.

Authors:  Lingegowda S Mangala; Banu Arun; Aysegul A Sahin; Kapil Mehta
Journal:  Mol Cancer       Date:  2005-09-09       Impact factor: 27.401

10.  Fission yeast Cyk3p is a transglutaminase-like protein that participates in cytokinesis and cell morphogenesis.

Authors:  Luther W Pollard; Masayuki Onishi; John R Pringle; Matthew Lord
Journal:  Mol Biol Cell       Date:  2012-05-09       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.